Lv6
1715 积分 2021-10-08 加入
Keep recycling going: New approaches to reduce LDL-C
7个月前
已完结
Inclisiran for the treatment of cardiovascular disease: the ORION clinical development program
7个月前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
9个月前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
1年前
已完结
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
1年前
已完结
The phage λ major tail protein structure reveals a common evolution for long-tailed phages and the type VI bacterial secretion system
2年前
已完结
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
2年前
已完结
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
2年前
已完结
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
2年前
已完结
The growth of siRNA-based therapeutics: Updated clinical studies
2年前
已完结
皖公网安备34019202002308
